Regen BioPharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $-1.4M | $113.2K |
| Jun 2017 | — | $-3.9M | $401.6K |
| Sep 2017 | — | $-5.3M | $270.0K |
| Dec 2017 | — | $-7.8M | $261.7K |
| Mar 2018 | — | $-8.5M | $31.1K |
| Jun 2018 | — | $-8.6M | $55.4K |
| Sep 2018 | — | $-9.1M | $8.0K |
| Dec 2018 | — | $-8.7M | $39.1K |
| Mar 2019 | — | $-8.8M | $15.1K |
| Jun 2019 | — | $-12.8M | $1.8K |
| Sep 2019 | — | $-10.9M | $7.9K |
| Dec 2019 | — | $-7.7M | $357 |
| Mar 2020 | — | $-11.8M | $0 |
| Jun 2020 | — | $-8.6M | $0 |
| Sep 2020 | — | $-7.3M | $0 |
| Dec 2020 | — | $-5.6M | $0 |
| Mar 2021 | — | $-5.1M | $0 |
| Jun 2021 | — | $-12.4M | $188.2K |
| Sep 2021 | — | $-13.5M | $727.2K |
| Dec 2021 | — | $-9.8M | $353.5K |
| Mar 2022 | — | $-76.7M | $234.7K |
| Jun 2022 | — | $-8.3M | $111.0K |
| Sep 2022 | — | $-8.0M | $51.2K |
| Dec 2022 | — | $-4.9M | $40.7K |
| Mar 2023 | — | $-4.9M | $87.7K |
| Jun 2023 | — | $-5.0M | $692 |
| Sep 2023 | — | $-5.1M | $121.0K |
| Dec 2023 | — | $-5.2M | $124.5K |
| Mar 2024 | — | $-5.2M | $78.1K |
| Jun 2024 | — | $-5.2M | $61.8K |
| Sep 2024 | — | $-5.2M | $716 |
| Dec 2024 | — | $-5.7M | $135 |
| Mar 2025 | — | $-5.7M | — |
| Jun 2025 | — | $-5.8M | — |
| Sep 2025 | — | $-6.3M | $69.6K |
| Dec 2025 | — | $-6.6M | $4.6K |
| Mar 2026 | — | $-5.4M | $271 |
| Jun 2026 | — | $-5.9M | $239 |